CHEBI:135076 - setiptiline

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name setiptiline
ChEBI ID CHEBI:135076
Definition A tetracyclic antidepressant that is 2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine carrying a methyl group at position 2. Its maleate salt is used for the treatment of depression in Japan.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C19H19N
Net Charge 0
Average Mass 261.368
Monoisotopic Mass 261.15175
InChI InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3
InChIKey GVPIXRLYKVFFMK-UHFFFAOYSA-N
SMILES CN1CCC2=C(C1)C1=C(CC3=C2C=CC=C3)C=CC=C1
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
Application(s): alpha-adrenergic antagonist
An agent that binds to but does not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous alpha-adrenergic agonists. alpha-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
serotonergic antagonist
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists.
antidepressant
Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions.
(via tetracyclic antidepressant )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing setiptiline (CHEBI:135076) has role α-adrenergic antagonist (CHEBI:37890)
setiptiline (CHEBI:135076) has role serotonergic antagonist (CHEBI:48279)
setiptiline (CHEBI:135076) is a tertiary amino compound (CHEBI:50996)
setiptiline (CHEBI:135076) is a tetracyclic antidepressant (CHEBI:50940)
setiptiline (CHEBI:135076) is conjugate base of setiptiline(1+) (CHEBI:176784)
Incoming setiptiline(1+) (CHEBI:176784) is conjugate acid of setiptiline (CHEBI:135076)
IUPAC Name
2-methyl-2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine
INNs Sources
setiptilina WHO MedNet
sétiptiline WHO MedNet
setiptiline WHO MedNet
setiptilinum WHO MedNet
Synonyms Sources
2,3,4,9-tetrahydro-2-methyl-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine ChemIDplus
MO 8282 ChemIDplus
MO-8282 DrugBank
Org 8282 DrugBank
Org-8282 DrugCentral
teciptilline DrugCentral
Manual Xrefs Databases
2438 DrugCentral
5016 ChemSpider
CN101851201 Patent
D08511 KEGG DRUG
DB09304 DrugBank
LSM-45982 LINCS
Setiptiline Wikipedia
US2006039867 Patent
View more database links
Registry Numbers Types Sources
1650422 Reaxys Registry Number Reaxys
57262-94-9 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
12935454 PubMed citation Europe PMC
1942625 PubMed citation Europe PMC
2045013 PubMed citation Europe PMC
2881854 PubMed citation Europe PMC
32285503 PubMed citation Europe PMC
3774630 PubMed citation Europe PMC
3792961 PubMed citation Europe PMC
8048280 PubMed citation Europe PMC
8968382 PubMed citation Europe PMC
9737336 PubMed citation Europe PMC
Last Modified
09 July 2021